| Year |
Citation |
Score |
| 2022 |
Hsu H, Chan MV, Armstrong PC, Crescente M, Donikian D, Kondo M, Brighton T, Chen V, Chen Q, Connor D, Joseph J, Morel-Kopp MC, Stevenson WS, Ward C, Warner TD, et al. A pilot study assessing the implementation of 96-well plate-based aggregometry (Optimul) in Australia. Pathology. PMID 35750510 DOI: 10.1016/j.pathol.2022.03.012 |
0.328 |
|
| 2021 |
Shen Y, Coyle L, Kerridge I, Stevenson W, Arthur C, McKinlay N, Fay K, Ward C, Greenwood M, Best OG, Solterbeck A, Guminski A, Shumack S, Mulligan SP. Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome. Ejhaem. 3: 129-138. PMID 35846218 DOI: 10.1002/jha2.366 |
0.725 |
|
| 2021 |
Rabbolini D, Liang HPH, Morel-Kopp MC, Connor D, Whittaker S, Dunkley S, Donikian D, Kondo M, Chen W, Stevenson WS, Campbell H, Joseph J, Ward C, Brighton T, Chen VM. Building platelet phenotypes: diaphanous-related formin 1 (DIAPH1)-related disorder. Platelets. 1-11. PMID 34223798 DOI: 10.1080/09537104.2021.1937593 |
0.354 |
|
| 2020 |
Gifford G, Stevenson W, Best G. Combination of the dual PIM/PI3-kinase inhibitor IBL-202 and venetoclax is effective in diffuse large B-cell lymphoma. Leukemia & Lymphoma. 1-12. PMID 32723130 DOI: 10.1080/10428194.2020.1795156 |
0.377 |
|
| 2020 |
Gifford GK, Gifford AJ, Chen Q, Shen Y, Gabrielli S, Gill AJ, Stevenson WS, Best OG. Fatty acid synthase and adenosine monophosphate-activated protein kinase regulate cell survival and drug sensitivity in diffuse large B-cell lymphoma. Leukemia & Lymphoma. 1-13. PMID 32249639 DOI: 10.1080/10428194.2020.1742899 |
0.553 |
|
| 2020 |
Wiggins M, Stevenson W. Genetic predisposition in acute leukaemia. International Journal of Laboratory Hematology. PMID 32115888 DOI: 10.1111/Ijlh.13173 |
0.31 |
|
| 2020 |
Tang C, Rabbolini DJ, Morel-Kopp MC, Connor DE, Crispin P, Ward CM, Stevenson WS. The clinical heterogeneity of associated familial platelet disorder with predisposition to myeloid malignancy - A case series and review of the literature. Research and Practice in Thrombosis and Haemostasis. 4: 106-110. PMID 31989091 DOI: 10.1002/rth2.12282 |
0.379 |
|
| 2020 |
Othman J, Armytage T, Wong K, Arthur C, Fay K, Stevenson W, MacKinlay N, Ward C, Pechey V, Coyle L, Kerridge I, Greenwood M. Intensive chemotherapy and up-front stem cell transplant for double hit lymphoma. Bone Marrow Transplantation. PMID 31959892 DOI: 10.1038/S41409-020-0789-5 |
0.426 |
|
| 2020 |
Rabbolini D, Connor D, Morel-Kopp MC, Donikian D, Kondo M, Chen W, Alessi MC, Stevenson W, Chen V, Joseph J, Brighton T, Ward C. An integrated approach to inherited platelet disorders: results from a research collaborative, the Sydney Platelet Group. Pathology. PMID 31932033 DOI: 10.1016/J.Pathol.2019.10.005 |
0.445 |
|
| 2019 |
Arthur C, Jeffrey A, Yip E, Katsioulas V, Nalpantidis A, Kerridge I, Greenwood M, Coyle L, Mackinlay N, Fay K, Enjeti A, Shortt J, Stevenson W. Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival. Leukemia & Lymphoma. 1-9. PMID 31809629 DOI: 10.1080/10428194.2019.1697876 |
0.356 |
|
| 2019 |
Crassini K, Stevenson WS, Mulligan SP, Best OG. Molecular pathogenesis of chronic lymphocytic leukaemia. British Journal of Haematology. PMID 31364161 DOI: 10.1111/Bjh.16102 |
0.749 |
|
| 2019 |
Keane C, Tobin J, Gunawardana J, Francis S, Gifford G, Gabrielli S, Gill A, Stevenson W, Talaulikar D, Gould C, Jain S, Birch S, Hertzberg M, Gandhi MK. The tumor microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV positive Diffuse Large B Cell Lymphoma. European Journal of Haematology. PMID 31211907 DOI: 10.1111/Ejh.13274 |
0.304 |
|
| 2018 |
Stein AS, Larson RA, Schuh AC, Stevenson W, Lech-Maranda E, Tran Q, Zimmerman Z, Kormany W, Topp MS. Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia. Blood Advances. 2: 1522-1531. PMID 29954814 DOI: 10.1182/Bloodadvances.2018019034 |
0.313 |
|
| 2018 |
Crassini K, Pyke T, Shen Y, Stevenson WS, Christopherson RI, Mulligan SP, Best OG. Inhibition of the Raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells. Leukemia & Lymphoma. 1-12. PMID 29911936 DOI: 10.1080/10428194.2018.1455974 |
0.746 |
|
| 2018 |
Crassini K, Shen Y, Stevenson WS, Christopherson R, Ward C, Mulligan SP, Best OG. MEK1/2 inhibition by binimetinib is effective as a single agent and potentiates the actions of Venetoclax and ABT-737 under conditions that mimic the chronic lymphocytic leukaemia (CLL) tumour microenvironment. British Journal of Haematology. PMID 29767411 DOI: 10.1111/Bjh.15282 |
0.744 |
|
| 2018 |
Crassini KR, Zhang E, Balendran S, Freeman JA, Best OG, Forsyth CJ, Mackinlay NJ, Han P, Stevenson WS, Mulligan SP. Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia. British Journal of Haematology. PMID 29468645 DOI: 10.1111/Bjh.15146 |
0.739 |
|
| 2018 |
Lindsay J, Sandaradura I, Wong K, Arthur C, Stevenson W, Kerridge I, Fay K, Coyle L, Greenwood M. 1139. Novel Formulation SUBA-Itraconazole Prophylaxis in Patients With Hematological Malignancy or Undergoing Allogeneic Stem Cell Transplantation: Follow-up Survival Data Open Forum Infectious Diseases. 5. DOI: 10.1093/Ofid/Ofy210.972 |
0.31 |
|
| 2017 |
Rabbolini DJ, Gardiner EE, Morel-Kopp MC, Dunkley S, Jahangiri A, Lee CS, Stevenson WS, Ward CM. Anti-glycoprotein VI mediated immune thrombocytopenia: An under-recognized and significant entity? Research and Practice in Thrombosis and Haemostasis. 1: 291-295. PMID 30046699 DOI: 10.1002/rth2.12033 |
0.346 |
|
| 2017 |
Mundell SJ, Rabbolini D, Gabrielli S, Chen Q, Aungraheeta R, Hutchinson JL, Kilo T, Mackay J, Ward CM, Stevenson W, Morel-Kopp MC. Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding. Journal of Thrombosis and Haemostasis : Jth. PMID 29117459 DOI: 10.1111/Jth.13900 |
0.302 |
|
| 2017 |
Rabbolini DJ, Chun Y, Latimer M, Kunishima S, Fixter K, Valecha B, Tan P, Chew LP, Kile BT, Burt R, Radhakrishnan K, Bird R, Ockelford P, Gabrielli S, Chen Q, ... Stevenson WS, et al. Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia. Platelets. 1-8. PMID 29090586 DOI: 10.1080/09537104.2017.1356920 |
0.39 |
|
| 2017 |
Lindsay J, Sandaradura I, Wong K, Arthur C, Stevenson W, Kerridge I, Fay K, Coyle L, Greenwood M. Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation. The Journal of Antimicrobial Chemotherapy. PMID 28961894 DOI: 10.1093/Jac/Dkx295 |
0.317 |
|
| 2017 |
Rabbolini DJ, Morel-Kopp MC, Chen Q, Gabrielli S, Dunlop LC, Chew LP, Blair N, Brighton TA, Singh N, Ng AP, Ward CM, Stevenson WS. Thrombocytopenia and CD34 expression is decoupled from α-granule deficiency with mutation of the first GFI1B zinc finger. Journal of Thrombosis and Haemostasis : Jth. PMID 28880435 DOI: 10.1111/jth.13843 |
0.346 |
|
| 2017 |
Rabbolini DJ, Morel-Kopp MC, Ward CM, Stevenson WS. GFI1B variants associated with thrombocytopenia. Platelets. 1-3. PMID 28580815 DOI: 10.1080/09537104.2017.1317734 |
0.317 |
|
| 2017 |
Keane C, Gould C, Gifford G, Stevenson W, Birch S, Tobin J, Talaulikar D, Jain S, Francis S, Matthew M, Gabrielli S, Abro E, Vari F, Gandhi M. Elevated Expression Of Lag3 Is Associated With Poor Outcome In Patients With Dlbcl Treated With R‐Chop Hematological Oncology. 35: 42-43. DOI: 10.1002/Hon.2437_24 |
0.301 |
|
| 2016 |
Douglas G, Harrison C, Forsyth C, Bennett M, Stevenson W, Hounsell J, Ratnasingam S, Ritchie D, Ross DM, Grigg A. Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea. Leukemia & Lymphoma. 1-7. PMID 27454522 DOI: 10.1080/10428194.2016.1187269 |
0.321 |
|
| 2016 |
Simeoni I, Stephens JC, Hu F, Deevi SV, Megy K, Bariana TK, Lentaigne C, Schulman S, Sivapalaratnam S, Vries MJ, Westbury SK, Greene D, Papadia S, Alessi MC, Attwood AP, ... ... Stevenson W, et al. A comprehensive high-throughput sequencing test for the diagnosis of inherited bleeding, thrombotic and platelet disorders. Blood. PMID 27084890 DOI: 10.1182/Blood-2015-12-688267 |
0.32 |
|
| 2015 |
Ho PJ, Marlton P, Tam C, Stevenson W, Ritchie D, Bird R, Dunlop LC, Durrant S, Ross DM. Practical management of myelofibrosis with ruxolitinib. Internal Medicine Journal. 45: 1221-30. PMID 26648193 DOI: 10.1111/Imj.12921 |
0.367 |
|
| 2015 |
Stevenson WS, Rabbolini DJ, Beutler L, Chen Q, Gabrielli S, Mackay JP, Brighton TA, Ward CM, Morel-Kopp MC. Paris-Trousseau thrombocytopenia is phenocopied by the autosomal recessive inheritance of a DNA-binding domain mutation in FLI1. Blood. PMID 26316623 DOI: 10.1182/Blood-2015-06-650887 |
0.36 |
|
| 2015 |
Crassini K, Stevenson WS, Mulligan SP, Best OG. The MEK1/2 inhibitor, MEKi-1, induces cell death in Chronic Lymphocytic Leukemia cells under conditions that mimic the tumor microenvironment and is synergistic with fludarabine. Leukemia & Lymphoma. 1-29. PMID 25804768 DOI: 10.3109/10428194.2015.1032963 |
0.745 |
|
| 2015 |
Estécio MR, Maddipoti S, Bueso-Ramos C, DiNardo CD, Yang H, Wei Y, Kondo K, Fang Z, Stevenson W, Chang KS, Pierce SA, Bohannan Z, Borthakur G, Kantarjian H, Garcia-Manero G. RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype. British Journal of Haematology. 169: 344-51. PMID 25612675 DOI: 10.1111/Bjh.13299 |
0.355 |
|
| 2015 |
Imlay-Gillespie L, Kliman DS, Wong K, Arthur C, Coyle L, Fay K, Kerridge IH, Mackinlay N, Mulligan S, Stevenson W, Ward CM, Greenwood M. Interim Positron Emission Tomography-Computed Tomography (PET-CT) Is Predictive of Post-Therapy Outcome in High Grade Transformation of Low Grade Lymphoproliferative Disorders Blood. 126: 5038-5038. DOI: 10.1182/Blood.V126.23.5038.5038 |
0.534 |
|
| 2015 |
Imlay-Gillespie L, Dix C, McEwan A, Wong K, Figtree M, Arthur C, Coyle L, Fay K, Greenwood M, Mackinlay N, Mulligan S, Stevenson W, Ward CM, Kerridge IH. Clostridium Difficile Infection in Haematology Patients Significantly Increases Length of Stay; A Case Control Study Blood. 126: 2108-2108. DOI: 10.1182/Blood.V126.23.2108.2108 |
0.571 |
|
| 2015 |
Rabbolini D, Morel-Kopp M, Gabrielli S, Chen W, Ward C, Stevenson W. Next generation sequencing using a candidate gene array for the diagnosis of uncharacterised inherited macrothrombocytopenias Pathology. 47. DOI: 10.1097/01.Pat.0000461594.21545.F2 |
0.435 |
|
| 2014 |
Rabbolini DJ, Morel-Kopp MC, Stevenson W, Ward CM. Inherited macrothrombocytopenias. Seminars in Thrombosis and Hemostasis. 40: 774-84. PMID 25173502 DOI: 10.1055/s-0034-1387922 |
0.357 |
|
| 2014 |
Stevenson WS, Best OG, Przybylla A, Chen Q, Singh N, Koleth M, Pierce S, Kennedy T, Tong W, Kuang SQ, Garcia-Manero G. DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia. Leukemia. 28: 787-93. PMID 24045499 DOI: 10.1038/leu.2013.270 |
0.566 |
|
| 2013 |
Singh NR, Morris CM, Koleth M, Wong K, Ward CM, Stevenson WS. Polyploidy in myelofibrosis: analysis by cytogenetic and SNP array indicates association with advancing disease. Molecular Cytogenetics. 6: 59. PMID 24341401 DOI: 10.1186/1755-8166-6-59 |
0.362 |
|
| 2013 |
Freeman JA, Crassini KR, Best OG, Forsyth CJ, Mackinlay NJ, Han P, Stevenson W, Mulligan SP. Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia. Leukemia & Lymphoma. 54: 99-104. PMID 22738394 DOI: 10.3109/10428194.2012.706285 |
0.727 |
|
| 2013 |
Best G, Gabrielli S, Miss, Zhu Y, Hayes M, Kuss BJ, Stevenson W, Mulligan SP. Genomic Profiling In Fit, Elderly Patients Receiving Oral Fludarabine, Oral Cyclophosphamide and Intravenous Rituximab (ALLG CLL5 OFOCIR trial) As Initial Treatment Of Chronic Lymphocytic Leukemia (CLL) Blood. 122: 1624-1624. DOI: 10.1182/Blood.V122.21.1624.1624 |
0.564 |
|
| 2012 |
Arthur C, Wong C, Aubrey B, Liu E, Stevenson W, Soo G, Coyle L, Fay K, Greenwood M, Mackinlay N, Ward CM. Progress Findings On a Novel Treatment Strategy Using Prolonged, Low-Dose Cytarabine and Thioguanine in Combination with Peg-Filgrastim for Acute Myeloid Leukaemia in Elderly Patients Blood. 120: 3612-3612. DOI: 10.1182/Blood.V120.21.3612.3612 |
0.358 |
|
| 2010 |
Dayyani F, Conley AP, Strom SS, Stevenson W, Cortes JE, Borthakur G, Faderl S, O'Brien S, Pierce S, Kantarjian H, Garcia-Manero G. Cause of death in patients with lower-risk myelodysplastic syndrome. Cancer. 116: 2174-9. PMID 20162709 DOI: 10.1002/Cncr.24984 |
0.374 |
|
| 2010 |
Tong WG, Wei Y, Stevenson W, Kuang SQ, Fang Z, Zhang M, Arts J, Garcia-Manero G. Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor Leukemia Research. 34: 221-228. PMID 19682743 DOI: 10.1016/J.Leukres.2009.07.024 |
0.304 |
|
| 2009 |
Tong W, Stevenson W, Cortes J, Needham L, Brotherton D, Davidson A, Drummond A, Garcia-Manero G. In vitro and in vivo anti-leukemia activity of CHR-2845, a cell-targeted HDAC inhibitor for use in monocytic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e14579. PMID 27963654 DOI: 10.1200/Jco.2009.27.15_Suppl.E14579 |
0.313 |
|
| 2008 |
Dayyani F, Conley AP, Pierce S, Strom S, Stevenson W, Borthakur G, Kantarjian H, Garcia-Manero G. Disease-Related Mortality in Patients with Lower-Risk Myelodysplastic Syndrome (MDS) Blood. 112: 5073-5073. DOI: 10.1182/Blood.V112.11.5073.5073 |
0.369 |
|
| 2008 |
Maddipoti SC, Bueso-Ramos C, Yang H, Fernandez M, Kuang S, Fang Z, Stevenson W, Wei Y, Pierce S, Garcia-Manero G. Epigenetic Silencing of the RUNX3 Gene by Promoter Hypermethylation in Patients with Acute Myeloid Leukemia. Blood. 112: 3341-3341. DOI: 10.1182/Blood.V112.11.3341.3341 |
0.329 |
|
| 2008 |
Tong W, Wei Y, Stevenson W, Kuang S, Arts J, Garcia-Manero G. Antileukemia Activity of JNJ-26481585, a Potent Second-Generation Histone Deacetylase Inhibitor Blood. 112: 2631-2631. DOI: 10.1182/Blood.V112.11.2631.2631 |
0.343 |
|
| Show low-probability matches. |